Skip to main content
Premium Trial:

Request an Annual Quote

Streck Signs Distribution Deal With Austria's Anopoli Biomedical

NEW YORK (GenomeWeb) – Clinical laboratory supply firm Streck announced today that it has signed a distribution agreement for its cell stabilization and molecular products with Austrian firm Anopoli Biomedical Systems.

Specific terms of the deal were not disclosed.

Streck's cell stabilization products include Cell-Free DNA BCT CE, a direct-draw blood collection tube that stabilizes nucleated blood cells and prevents the release of genomic DNA; and Cell-Free RNA BCT CE, a blood collection tube containing a preservative that stabilizes circulating RNA in plasma and prevents the release of non-target background RNA from blood cells during sample processing and storage.

The firm's molecular products include the Arm-D kits for detecting antibiotic resistance genes by multiplex real-time PCR, and the soon-to-be-launched rapid real-time PCR instrument Zulu RT.

The deal with Anopoli comes just weeks after Streck inked distribution deals for its products in Switzerland and China.